https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-01 / Curr. Opin. Mol. Ther. 2006 Feb;8(1):46-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-01 / Curr. Opin. Mol. Ther. 2006 Feb;8(1):46-512006-02-01 00:00:002019-02-15 09:00:02Novel immunotherapeutic approaches to glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Clin Neurosurg 2006;53:345-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Clin Neurosurg 2006;53:345-512006-01-01 00:00:002019-02-15 08:59:51Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-01 / Ann. N. Y. Acad. Sci. 2005 Dec;1062:13-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-01 / Ann. N. Y. Acad. Sci. 2005 Dec;1062:13-212005-12-01 00:00:002019-02-15 09:00:03Harnessing the immune system against human glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / J. Neurooncol. 2005 Nov;75(2):111-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / J. Neurooncol. 2005 Nov;75(2):111-82005-11-01 00:00:002019-02-15 09:00:04Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-28 / Mol. Ther. 2006 Jan;13(1):221-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-28 / Mol. Ther. 2006 Jan;13(1):221-82005-10-28 00:00:002019-02-15 09:00:17Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-01 / Nippon Rinsho 2005 Sep;63 Suppl 9:483-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-01 / Nippon Rinsho 2005 Sep;63 Suppl 9:483-92005-09-01 00:00:002019-02-15 09:00:05[Current status of hyperthermia for therapy of brain tumor]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-252005-08-01 00:00:002019-02-15 08:46:55Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-01 / J. Neurosurg. 2005 Jul;103(1):156-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-01 / J. Neurosurg. 2005 Jul;103(1):156-642005-07-01 00:00:002019-02-15 09:00:06Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-06-01 / Clin. Cancer Res. 2005 Jun;11(11):4160-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-06-01 / Clin. Cancer Res. 2005 Jun;11(11):4160-72005-06-01 00:00:002019-02-15 08:46:56Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-04-01 / J. Neurooncol. 2005 Apr;72(2):107-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-04-01 / J. Neurooncol. 2005 Apr;72(2):107-132005-04-01 00:00:002019-02-15 08:46:57Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
